Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.43

+0.2%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (266)	5/26/1999 1:50:00 PM
From: scaram(o)uche	Read Replies (1) of 1475

the version for popular digestion...... biz.yahoo.com Recent studies published..... (1) graft-versus-lymphoma with long-term remission in two of four evaluable/terminal patients, and (2) liver transplantation using the murine precursor for 507. Studies to be described soon.... MEDI and phase II, 507 for GvH. Market capitalization....... 29 million.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next